Myomo MYO
NYSE MYO
$1.73 -0.01 (-0.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

Myomo (MYO) Cash from Investing Activities (2017 - 2025)

Myomo's (MYO) quarterly Cash from Investing Activities came in at $189698.0 in Q3 2025, down 93.29% YoY from $2.8 million in Q3 2024, and up 125.05% on a QoQ basis from -$757348.0 in Q2 2025.

Myomo (MYO) Cash from Investing Activities (2017 - 2025) Analysis & Trends

Myomo (MYO) has 9 years of Cash from Investing Activities data on file, last reported at $189698.0 in Q3 2025.

  • Quarterly Cash from Investing Activities fell 93.29% year-over-year to $189698.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$3.8 million (down 197.68% YoY) and the FY2024 annual result came in at $259981.0, up 112.81% from the prior year.
  • Cash from Investing Activities improved to $189698.0 in Q3 2025, from -$757348.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.8 million in Q3 2024 to a low of -$3.5 million in Q1 2024.
  • A 5-year average of -$256346.7 and a median of -$52793.0 in 2022 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 67882.92% in 2023, down 22831.05% in 2023.
  • Tracing MYO's Cash from Investing Activities over 5 years: stood at -$23935.0 in 2021, then jumped by 85.86% to -$3385.0 in 2022, then jumped by 67882.92% to $2.3 million in 2023, then sank by 158.98% to -$1.4 million in 2024, then surged by 114.02% to $189698.0 in 2025.
  • The last three Cash from Investing Activities figures came in at $189698.0 (Q3 2025), -$757348.0 (Q2 2025), and -$1.9 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -673.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -639.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -193.20 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -22.08 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -108.50 Mn
10 Myomo 67.26 Mn 48.29 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 189,698.00
Sep 30, 2025 189,698.00
Jun 30, 2025 -757,348.00
Jun 30, 2025 -757,348.00
Mar 31, 2025 -1.90 Mn
Mar 31, 2025 -1.90 Mn
Dec 31, 2024 -1.35 Mn
Dec 31, 2024 -1.35 Mn
Sep 30, 2024 2.83 Mn
Sep 30, 2024 2.83 Mn
Jun 30, 2024 2.33 Mn
Jun 30, 2024 2.33 Mn
Mar 31, 2024 -3.54 Mn
Mar 31, 2024 -3.54 Mn
Dec 31, 2023 2.29 Mn
Dec 31, 2023 2.29 Mn
Sep 30, 2023 -1.32 Mn
Sep 30, 2023 -1.32 Mn
Jun 30, 2023 -2.96 Mn
Jun 30, 2023 -2.96 Mn